Eye Care News — ScienceDaily Learn about glaucoma symptoms and cataracts, as well as laser eye surgery and optic nerve regeneration. Read the latest medical research on diagnosis and new treatment options.
- New study reveals serious long-term complications in youth-onset type 2 diabeteson July 29, 2021 at 12:13 am
Findings underscore the importance of early, intensive treatment. The study focused on complications of youth-onset type 2 diabetes. Overall, researchers saw a steady decline in blood glucose control over 15 years.
- Scientists discover gene therapy provides neuroprotection to prevent glaucoma vision losson July 22, 2021 at 3:30 pm
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to new research. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness.
- Wearable devices can reduce collision risk in blind and visually impaired peopleon July 22, 2021 at 3:29 pm
A new randomized controlled trial shows wearing a vibrating collision device can reduce collisions in people who are blind and visually impaired, adding a potential new tool that can be used by these populations in addition to a long cane, to ensure independent travel safety.
- Glaucoma test ‘best yet’on July 15, 2021 at 4:46 pm
The latest investigations into a promising new genetic test for glaucoma – the leading cause of blindness worldwide – has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.
- New study suggests benefit-to-harm balance of statins for healthy adults ‘generally favorable’on July 14, 2021 at 10:34 pm
Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, say researchers.
ONE News Feed This is a ONE News feed
- Office-based therapies benefit children with convergence insufficiencyon July 28, 2021 at 1:00 pm
This Ophthalmic Technology Assessment evaluates home- and office-based vergence and accommodative therapies for treatment of convergence insufficiency (CI) in young patients.
- Study sheds light on diplopia among patients with glaucoma drainage deviceson July 26, 2021 at 1:00 pm
This prospective cohort study describes the prevalence of diplopia in patients with various glaucoma drainage devices.
- 25-gauge PPV for acute retinal necrosis-related RRD yields good anatomical outcomeson July 22, 2021 at 1:00 pm
Investigators report the anatomic and functional outcomes of 25-guage pars plana vitrectomy (PPV) for acute retinal necrosis (ARN)-related rhegmatogenous retinal detachment (RRD).
- A case of acute abducens nerve palsy after COVID-19 vaccinationon July 21, 2021 at 1:00 pm
This paper describes a patient who presented with acute abducens nerve palsy after receiving the Pfizer-BioNTech COVID-19 vaccine.
- Vitreous biopsies reveal potential uveal melanoma biomarkerson July 15, 2021 at 1:00 pm
In this study, investigators use proteomics to identify potential biomarkers for uveal melanoma and candidate targets for drug repositioning.